A new era of non-invasive prenatal genetic diagnosis: Exploiting fetal epigenetic differences

Clinical Genetics

Volumn 81, Issue 4, 2012, Pages 362-363

  Ladha, S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

AMNIOCENTESIS; CHORION VILLUS SAMPLING; CHROMOSOME 21; CHROMOSOME ABERRATION; DNA DETERMINATION; DNA METHYLATION; EPIGENETICS; GENETIC ANALYSIS; HUMAN; IMMUNOPRECIPITATION; NON INVASIVE PRENATAL GENETIC DIAGNOSIS; NON INVASIVE PROCEDURE; NOTE; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; TRISOMY 21;

EID: 84858294180     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2011.01835.x     Document Type: Note

References (3)

1. Papergeorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nature Med 2011: 17: 510-513.
2. Society of Obstetricians and Gynaecologists of Canada. Canadian Guidelines for Prenatal Diagnosis. J Obstet Gynaecol Can 2001: 23: 616-624.
3. Rakyan VK, Down TA, Thorne NP et al. An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res 2008: 18: 1518-1529.